Viewing Study NCT04619433


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2026-01-08 @ 8:23 PM
Study NCT ID: NCT04619433
Status: TERMINATED
Last Update Posted: 2025-09-23
First Post: 2020-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module